Erik Jongert

4.5k total citations
47 papers, 2.2k citations indexed

About

Erik Jongert is a scholar working on Epidemiology, Immunology and Virology. According to data from OpenAlex, Erik Jongert has authored 47 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 19 papers in Immunology and 16 papers in Virology. Recurrent topics in Erik Jongert's work include Malaria Research and Control (14 papers), Toxoplasma gondii Research Studies (13 papers) and Herpesvirus Infections and Treatments (12 papers). Erik Jongert is often cited by papers focused on Malaria Research and Control (14 papers), Toxoplasma gondii Research Studies (13 papers) and Herpesvirus Infections and Treatments (12 papers). Erik Jongert collaborates with scholars based in Belgium, United States and United Kingdom. Erik Jongert's co-authors include Aize Kijlstra, Stéphane De Craeye, Philippe Moris, Eskild Petersen, Nicola Gargano, Robbert van der Most, Elisabeth Förster‐Waldl, Opokua Ofori‐Anyinam, Craig W. Roberts and Marie‐Ange Demoitié and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Scientific Reports.

In The Last Decade

Erik Jongert

46 papers receiving 2.2k citations

Peers

Countries citing papers authored by Erik Jongert

Since Specialization

Citations

This map shows the geographic impact of Erik Jongert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Jongert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Jongert more than expected).

Fields of papers citing papers by Erik Jongert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Jongert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Jongert. The network helps show where Erik Jongert may publish in the future.

Co-authorship network of co-authors of Erik Jongert

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Jongert. A scholar is included among the top collaborators of Erik Jongert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Jongert. Erik Jongert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A tool for evaluating heterogeneity in avidity of polyclonal antibodies 2023 ·Frontiers in Immunology ·Kan Li, Michael Dodds, Rachel L. Spreng, (unknown), (unknown), (unknown), (unknown), Sheetij Dutta, Ulrike Wille-Reece, Erik Jongert, Katie Ewer, Adrian V. S. Hill, Celina Jin, Jennifer Hill, Andrew J. Pollard, S. Munir Alam, Georgia D. Tomaras, S. Moses Dennison	4
2	Delayed fractional dosing with RTS,S/AS01 improves humoral immunity to malaria via a balance of polyfunctional NANP6- and Pf16-specific antibodies 2021 ·Med ·Jishnu Das, Jonathan K. Fallon, Timothy C. Yu, Ashlin R. Michell, Todd J. Suscovich, Caitlyn Linde, Harini Natarajan, Joshua A. Weiner, Margherita Coccia, (unknown), Margaret E. Ackerman, Elke S. Bergmann‐Leitner, Laura Fontana, Sheetij Dutta, Douglas A. Lauffenburger, Erik Jongert, Ulrike Wille-Reece, Galit Alter	19
3	A delayed fractionated dose RTS,S AS01 vaccine regimen mediates protection via improved T follicular helper and B cell responses 2020 ·eLife ·Suresh Pallikkuth, Sidhartha Chaudhury, Pinyi Lu, Li Pan, Erik Jongert, Ulrike Wille-Reece, Savita Pahwa	32
4	Long-term safety and immunogenicity of the M72/AS01E candidate tuberculosis vaccine in HIV-positive and -negative Indian adults 2018 ·Medicine ·Nagalingeswaran Kumarasamy, Selvamuthu Poongulali, (unknown), (unknown), (unknown), Anne Bollaerts, Marie‐Ange Demoitié, Erik Jongert, Opokua Ofori‐Anyinam, Olivier Van Der Meeren	24
5	Adjuvant-Associated Peripheral Blood mRNA Profiles and Kinetics Induced by the Adjuvanted Recombinant Protein Candidate Tuberculosis Vaccine M72/AS01 in Bacillus Calmette–Guérin-Vaccinated Adults 2018 ·Frontiers in Immunology ·Robert A. van den Berg, Laurane De Mot, Geert Leroux‐Roels, Viviane Bechtold, Frédéric Clément, Margherita Coccia, Erik Jongert, Thomas G. Evans, Paul Gillard, Robbert van der Most	28
6	Delayed fractional dose regimen of the RTS,S/AS01 malaria vaccine candidate enhances an IgG4 response that inhibits serum opsonophagocytosis 2017 ·Scientific Reports ·Sidhartha Chaudhury, Jason A. Regules, (unknown), Sheetij Dutta, Anders Wallqvist, Norman C. Waters, Erik Jongert, Franck Lemiale, Elke S. Bergmann‐Leitner	36
7	A Randomized, Controlled Safety, and Immunogenicity Trial of the M72/AS01 Candidate Tuberculosis Vaccine in HIV-Positive Indian Adults 2016 ·Medicine ·Nagalingeswaran Kumarasamy, Selvamuthu Poongulali, Anne Bollaerts, Philippe Moris, (unknown), (unknown), Marie‐Ange Demoitié, Erik Jongert, Opokua Ofori‐Anyinam	35
8	The biological function of antibodies induced by the RTS,S/AS01 malaria vaccine candidate is determined by their fine specificity 2016 ·Malaria Journal ·Sidhartha Chaudhury, Christian F. Ockenhouse, Jason A. Regules, Sheetij Dutta, Anders Wallqvist, Erik Jongert, Norman C. Waters, Franck Lemiale, Elke S. Bergmann‐Leitner	54
9	A monoclonal antibody-based immunoassay to measure the antibody response against the repeat region of the circumsporozoite protein of Plasmodium falciparum 2016 ·Malaria Journal ·(unknown), Frédéric Clément, Erik Jongert, Yann G.‐J. Sterckx, Christian F. Ockenhouse, Jason A. Regules, Franck Lemiale, Geert Leroux‐Roels	8
10	Safety and immunogenicity of candidate vaccine M72/AS01E in adolescents in a TB endemic setting 2015 ·Vaccine ·Adam Penn‐Nicholson, Hennie Geldenhuys, Wivine Burny, Robbert van der Most, Cheryl L. Day, Erik Jongert, Philippe Moris, Mark Hatherill, Opokua Ofori‐Anyinam, Willem A. Hanekom, (unknown), Marie‐Ange Demoitié, Angelique Kany Kany Luabeya, (unknown), Michèle Tameris, Didier Lapierre, Thomas J. Scriba	92
11	Evaluation of the immune response to RTS,S/AS01 and RTS,S/AS02 adjuvanted vaccines 2014 ·Human Vaccines & Immunotherapeutics ·Geert Leroux‐Roels, Isabel Leroux‐Roels, Frédéric Clément, Opokua Ofori‐Anyinam, Marc Lievens, Erik Jongert, Philippe Moris, W. Ripley Ballou, Joe Cohen	45
12	Immunogenicity and safety of the candidate RTS,S/AS01 vaccine in young Nigerian children: A randomized, double-blind, lot-to-lot consistency trial 2014 ·Vaccine ·Rich Umeh, Stephen Oguche, Tagbo Oguonu, (unknown), Elvis Shu, (unknown), (unknown), (unknown), (unknown), Erik Jongert, Grégory Catteau, Marc Lievens, Opokua Ofori‐Anyinam, Amanda Leach	6
13	Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine when given as a booster to BCG in Gambian infants: An open-label randomized controlled trial 2014 ·Tuberculosis ·Olubukola T. Idoko, Olumuyiwa Owolabi, Patrick K. Owiafe, Philippe Moris, Aderonke Odutola, Anne Bollaerts, Ezra Olatunde Ogundare, Erik Jongert, Marie‐Ange Demoitié, Opokua Ofori‐Anyinam, Martin O. C. Ota	42
14	Effect of ingested human antibodies induced by RTS, S/AS01 malaria vaccination in children on Plasmodium falciparum oocyst formation and sporogony in mosquitoes 2014 ·Malaria Journal ·Kazutoyo Miura, Erik Jongert, Bingbing Deng, (unknown), John Lusingu, Chris Drakeley, Michael P. Fay, Carole A. Long, Johan Vekemans	4
15	The candidate tuberculosis vaccine Mtb72F/AS02 in PPD positive adults: A randomized controlled phase I/II study 2012 ·Tuberculosis ·François Spertini, R Audran, (unknown), Opokua Ofori‐Anyinam, (unknown), Pierre Vandepapelière, Philippe Moris, Marie‐Ange Demoitié, Pascal Mettens, (unknown), (unknown), Erik Jongert, Joe Cohen, W. Ripley Ballou	42
16	IFN-γ expression and infectivity of Toxoplasma infected tissues are associated with an antibody response against GRA7 in experimentally infected pigs 2011 ·Veterinary Parasitology ·(unknown), Stéphane De Craeye, Pierre Dorny, Vesna Melkebeek, Bruno Goddeeris, Eric Cox, Erik Jongert	22
17	Functional characterization of in vivo effector CD4+ and CD8+ T cell responses in acute Toxoplasmosis: An interplay of IFN-γ and cytolytic T cells 2010 ·Vaccine ·Erik Jongert, Arnaud Lemière, Jo A. Van Ginderachter, Stéphane De Craeye, Kris Huygen, Sushila D’Souza	37
18	Prevalence of Toxoplasma gondii infection in Belgian house cats 2008 ·Veterinary Parasitology ·Stéphane De Craeye, (unknown), (unknown), Veerle de Vriendt, Steven Van Gucht, (unknown), Erik Jongert	22
19	Control of the risk of human toxoplasmosis transmitted by meat 2008 ·International Journal for Parasitology ·Aize Kijlstra, Erik Jongert	269
20	The role of rodents and shrews in the transmission of Toxoplasma gondii to pigs 2008 ·Veterinary Parasitology ·Aize Kijlstra, B.G. Meerburg, J.B.W.J. Cornelissen, Stéphane De Craeye, P. Vereijken, Erik Jongert	109

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact